A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterations

Drew Pratt^#¹, Chandan Kumar-Sinha^#^{2

3}, Marcin Cieślik^{2

4}, Rohit Mehra^{2

3}, Hong Xiao², Lina Shao², Andrea Franson⁵, Evan Cantor⁵, Arul M Chinnaiyan^{2

3}, Rajen Mody⁵, Zied Abdullaev⁶, Kenneth Aldape⁶, Martha Quezado⁶, Sandra Camelo-Piragua⁷

Affiliations

¹ Department of Pathology, University of Michigan, NCRC Bldg 35, 2800 Plymouth Rd, Ann Arbor, MI, 48104, USA. prattdr@med.umich.edu.
² Department of Pathology, University of Michigan, NCRC Bldg 35, 2800 Plymouth Rd, Ann Arbor, MI, 48104, USA.
³ Michigan Center for Translational Pathology, Ann Arbor, MI, USA.
⁴ Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
⁵ Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
⁶ Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
⁷ Department of Pathology, University of Michigan, NCRC Bldg 35, 2800 Plymouth Rd, Ann Arbor, MI, 48104, USA. sandraca@med.umich.edu.

^# Contributed equally.

Case Reports

Drew Pratt et al. Acta Neuropathol. 2021 Apr.

. 2021 Apr;141(4):619-622.

doi: 10.1007/s00401-021-02278-3. Epub 2021 Feb 7.

¹ Department of Pathology, University of Michigan, NCRC Bldg 35, 2800 Plymouth Rd, Ann Arbor, MI, 48104, USA. prattdr@med.umich.edu.
² Department of Pathology, University of Michigan, NCRC Bldg 35, 2800 Plymouth Rd, Ann Arbor, MI, 48104, USA.
³ Michigan Center for Translational Pathology, Ann Arbor, MI, USA.
⁴ Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
⁵ Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
⁶ Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
⁷ Department of Pathology, University of Michigan, NCRC Bldg 35, 2800 Plymouth Rd, Ann Arbor, MI, 48104, USA. sandraca@med.umich.edu.

^# Contributed equally.

No abstract available

References

1. Antonescu CR, Owosho AA, Zhang L, Chen S, Deniz K, Huryn JM et al (2017) Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol 41:941–949. https://doi.org/10.1097/PAS.0000000000000846 - DOI - PubMed - PMC
1. Bielle F, Zanello M, Guillemot D, Gil-Delgado M, Bertrand A, Boch AL et al (2014) Unusual primary cerebral localization of a CIC–DUX4 translocation tumor of the Ewing sarcoma family. Acta Neuropathol 128:309–311. https://doi.org/10.1007/s00401-014-1312-0 - DOI - PubMed
1. Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000 - DOI - PubMed - PMC
1. Castel D, Kergrohen T, Tauziede-Espariat A, Mackay A, Ghermaoui S, Lechapt E et al (2020) Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3–K27M mutation. Acta Neuropathol 139:1109–1113. https://doi.org/10.1007/s00401-020-02142-w - DOI - PubMed
1. Fults D, Pedone CA, Morse HG, Rose JW, McKay RD (1992) Establishment and characterization of a human primitive neuroectodermal tumor cell line from the cerebral hemisphere. J Neuropathol Exp Neurol 51:272–280. https://doi.org/10.1097/00005072-199205000-00005 - DOI - PubMed